{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T10:10:49Z","timestamp":1756894249788},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,6,3]],"date-time":"2021-06-03T00:00:00Z","timestamp":1622678400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,6,3]],"date-time":"2021-06-03T00:00:00Z","timestamp":1622678400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"NIH","award":["R21DA042325-01"],"award-info":[{"award-number":["R21DA042325-01"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Stimuli previously paired with drugs of dependence can produce cravings that are associated with increased dopamine (DA) levels in limbic and striatal brain areas. Positron Emission Tomography (PET) imaging with [<jats:sup>11<\/jats:sup>C]-(+)-PHNO allows for a sensitive measurement of changes in DA levels. The purpose of the present study was to investigate changes in DA levels, measured with PET imaging with [<jats:sup>11<\/jats:sup>C]-(+)-PHNO, in regions of interest in smokers who had maintained abstinence for 7\u201310\u00a0days. Participants (N\u2009=\u200910) underwent two PET scans on separate days, during which they viewed either smoking-related or neutral images, in counterbalanced order. Craving was measured with the 12-item Tobacco Craving Questionnaire (TCQ) and the Questionnaire on Smoking Urges-Brief (QSU-B). Compared to neutral cues, smoking cues did not increase craving. There were no changes in [<jats:sup>11<\/jats:sup>C]-(+)-PHNO binding in the cue condition compared to the neutral condition for most regions of interest (ventral pallidum, globus pallidus, limbic striatum, associative striatum, sensorimotor striatum). However, binding potential in the substantia nigra was greater in the smoking-cue condition, indicating decreased synaptic dopamine. There is a potential change of DA level occurring in midbrain following the presentation of smoking-related cues. However, this preliminary finding would need to be validated with a larger sample.<\/jats:p>","DOI":"10.1038\/s41598-021-90915-y","type":"journal-article","created":{"date-parts":[[2021,6,3]],"date-time":"2021-06-03T10:15:03Z","timestamp":1622715303000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The influence of conditioned stimuli on [11C]-(+)-PHNO PET binding in tobacco smokers after a one week abstinence"],"prefix":"10.1038","volume":"11","author":[{"given":"Patricia","family":"Di Ciano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harriet","family":"de Wit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esmaeil","family":"Mansouri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sylvain","family":"Houle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabelle","family":"Boileau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernard","family":"Le Foll","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,6,3]]},"reference":[{"key":"90915_CR1","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.ejphar.2005.09.024","volume":"526","author":"P Di Ciano","year":"2005","unstructured":"Di Ciano, P. & Everitt, B. J. Neuropsychopharmacology of drug seeking: Insights from studies with second-order schedules of drug reinforcement. Eur. J. Pharmacol. 526, 186\u2013198 (2005).","journal-title":"Eur. J. Pharmacol."},{"key":"90915_CR2","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1007\/BF00432175","volume":"75","author":"H de Wit","year":"1981","unstructured":"de Wit, H. & Stewart, J. Reinstatement of cocaine-reinforced responding in the rat. Psychopharmacology 75, 134\u2013143 (1981).","journal-title":"Psychopharmacology"},{"key":"90915_CR3","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/S0091-3057(01)00676-1","volume":"70","author":"AR Caggiula","year":"2001","unstructured":"Caggiula, A. R. et al. Cue dependency of nicotine self-administration and smoking. Pharmacol. Biochem. Behav. 70, 515\u2013530 (2001).","journal-title":"Pharmacol. Biochem. Behav."},{"key":"90915_CR4","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1007\/s00213-002-1156-5","volume":"163","author":"AR Caggiula","year":"2002","unstructured":"Caggiula, A. R. et al. Environmental stimuli promote the acquisition of nicotine self-administration in rats. Psychopharmacology 163, 230\u2013237 (2002).","journal-title":"Psychopharmacology"},{"key":"90915_CR5","doi-asserted-by":"publisher","DOI":"10.1093\/ntr\/ntaa147","author":"JM Betts","year":"2020","unstructured":"Betts, J. M., Dowd, A. N., Forney, M., Hetelekides, E. & Tiffany, S. T. A meta-analysis of cue reactivity in tobacco cigarette smokers. Nicotine Tob. Res. https:\/\/doi.org\/10.1093\/ntr\/ntaa147 (2020).","journal-title":"Nicotine Tob. Res."},{"key":"90915_CR6","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/0376-8716(95)01118-I","volume":"38","author":"G Di Chiara","year":"1995","unstructured":"Di Chiara, G. The role of dopamine in drug-abuse viewed from the perspective of its role in motivation. Drug Alcohol Depend. 38, 95\u2013137 (1995).","journal-title":"Drug Alcohol Depend."},{"key":"90915_CR7","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1046\/j.1460-9568.1998.00125.x","volume":"10","author":"P Di Ciano","year":"1998","unstructured":"Di Ciano, P., Blaha, C. D. & Phillips, A. G. Conditioned changes in dopamine oxidation currents in the nucleus accumbens of rats by stimuli paired with self-administration or yoked-administration of d-amphetamine. Eur. J. Neurosci. 10, 1121\u20131127 (1998).","journal-title":"Eur. J. Neurosci."},{"key":"90915_CR8","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1046\/j.1460-9568.1998.00124.x","volume":"10","author":"P Di Ciano","year":"1998","unstructured":"Di Ciano, P., Blaha, C. D. & Phillips, A. G. The relation between dopamine oxidation currents in the nucleus accumbens and conditioned increases in motor activity in rats following repeated administration of d-amphetamine or cocaine. Eur. J. Neurosci. 10, 1113\u20131120 (1998).","journal-title":"Eur. J. Neurosci."},{"key":"90915_CR9","doi-asserted-by":"publisher","first-page":"7489","DOI":"10.1523\/JNEUROSCI.20-19-07489.2000","volume":"20","author":"R Ito","year":"2000","unstructured":"Ito, R., Dalley, J. W., Howes, S. R., Robbins, T. W. & Everitt, B. J. Dissociation in conditioned dopamine release in the nucleus accumbens core and shell in response to cocaine cues and during cocaine-seeking behavior in rats. J. Neurosci. 20, 7489\u20137495 (2000).","journal-title":"J. Neurosci."},{"key":"90915_CR10","doi-asserted-by":"publisher","first-page":"4130","DOI":"10.1523\/JNEUROSCI.14-07-04130.1994","volume":"14","author":"A Gratton","year":"1994","unstructured":"Gratton, A. & Wise, R. A. Drug- and behavior-associated changes in dopamine-related electrochemical signals during intravenous cocaine self-administration in rats. J. Neurosci. 14, 4130\u20134146 (1994).","journal-title":"J. Neurosci."},{"key":"90915_CR11","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/0304-3940(96)12731-2","volume":"211","author":"EA Kiyatkin","year":"1996","unstructured":"Kiyatkin, E. A. & Stein, E. A. Conditioned changes in nucleus accumbens dopamine signal established by intravenous cocaine in rats. Neurosci. Lett. 211, 73\u201376 (1996).","journal-title":"Neurosci. Lett."},{"key":"90915_CR12","doi-asserted-by":"publisher","first-page":"3998","DOI":"10.1523\/JNEUROSCI.4370-06.2007","volume":"27","author":"I Boileau","year":"2007","unstructured":"Boileau, I. et al. Conditioned dopamine release in humans: A positron emission tomography [11C]raclopride study with amphetamine. J. Neurosci. 27, 3998\u20134003 (2007).","journal-title":"J. Neurosci."},{"key":"90915_CR13","doi-asserted-by":"publisher","first-page":"46665","DOI":"10.1038\/srep46665","volume":"7","author":"SML Cox","year":"2017","unstructured":"Cox, S. M. L. et al. Cocaine cue-induced dopamine release in recreational cocaine users. Sci. Rep. 7, 46665. https:\/\/doi.org\/10.1038\/srep46665 (2017).","journal-title":"Sci. Rep."},{"key":"90915_CR14","doi-asserted-by":"publisher","first-page":"6583","DOI":"10.1523\/JNEUROSCI.1544-06.2006","volume":"26","author":"ND Volkow","year":"2006","unstructured":"Volkow, N. D. et al. Cocaine cues and dopamine in dorsal striatum: Mechanism of craving in cocaine addiction. J. Neurosci. 26, 6583\u20136588 (2006).","journal-title":"J. Neurosci."},{"key":"90915_CR15","doi-asserted-by":"publisher","first-page":"2716","DOI":"10.1038\/sj.npp.1301194","volume":"31","author":"DF Wong","year":"2006","unstructured":"Wong, D. F. et al. Increased occupancy of dopamine receptors in human striatum during cue-elicited cocaine craving. Neuropsychopharmacology 31, 2716\u20132727 (2006).","journal-title":"Neuropsychopharmacology"},{"key":"90915_CR16","doi-asserted-by":"publisher","first-page":"1780","DOI":"10.1038\/npp.2013.77","volume":"38","author":"A Fotros","year":"2013","unstructured":"Fotros, A. et al. Cocaine cue-induced dopamine release in amygdala and hippocampus: A high-resolution PET [(1)(8)F]fallypride study in cocaine dependent participants. Neuropsychopharmacology 38, 1780\u20131788. https:\/\/doi.org\/10.1038\/npp.2013.77 (2013).","journal-title":"Neuropsychopharmacology"},{"key":"90915_CR17","doi-asserted-by":"publisher","first-page":"e60382","DOI":"10.1371\/journal.pone.0060382","volume":"8","author":"L Chiuccariello","year":"2013","unstructured":"Chiuccariello, L. et al. Presentation of Smoking-Associated Cues does not elicit dopamine release after one-hour smoking abstinence: A [(11)C]-(+)-PHNO PET study. PLoS ONE 8, e60382. https:\/\/doi.org\/10.1371\/journal.pone.0060382 (2013).","journal-title":"PLoS ONE"},{"key":"90915_CR18","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/35084134","volume":"412","author":"JW Grimm","year":"2001","unstructured":"Grimm, J. W., Hope, B. T., Wise, R. A. & Shaham, Y. Neuroadaptation. Incubation of cocaine craving after withdrawal. Nature 412, 141\u2013142 (2001).","journal-title":"Nature"},{"key":"90915_CR19","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/j.biopsych.2010.07.014","volume":"69","author":"G Bedi","year":"2011","unstructured":"Bedi, G. et al. Incubation of cue-induced cigarette craving during abstinence in human smokers. Biol. Psychiatry 69, 708\u2013711 (2011).","journal-title":"Biol. Psychiatry"},{"key":"90915_CR20","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1111\/j.1471-4159.2006.03840.x","volume":"97","author":"N Ginovart","year":"2006","unstructured":"Ginovart, N. et al. Binding characteristics and sensitivity to endogenous dopamine of [11C]-(+)-PHNO, a new agonist radiotracer for imaging the high-affinity state of D2 receptors in vivo using positron emission tomography. J. Neurochem. 97, 1089\u20131103 (2006).","journal-title":"J. Neurochem."},{"key":"90915_CR21","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1038\/sj.npp.1301400","volume":"33","author":"M Willeit","year":"2008","unstructured":"Willeit, M. et al. First human evidence of d-amphetamine induced displacement of a D2\/3 agonist radioligand: A [11C]-(+)-PHNO positron emission tomography study. Neuropsychopharmacology 33, 279\u2013289. https:\/\/doi.org\/10.1038\/sj.npp.1301400 (2008).","journal-title":"Neuropsychopharmacology"},{"key":"90915_CR22","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1038\/jcbfm.2011.115","volume":"32","author":"P Shotbolt","year":"2012","unstructured":"Shotbolt, P. et al. Within-subject comparison of [(11)C]-(+)-PHNO and [(11)C]raclopride sensitivity to acute amphetamine challenge in healthy humans. J. Cereb. Blood Flow Metab. 32, 127\u2013136. https:\/\/doi.org\/10.1038\/jcbfm.2011.115 (2012).","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"90915_CR23","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/npp.2013.209","volume":"39","author":"B Le Foll","year":"2014","unstructured":"Le Foll, B. et al. Elevation of dopamine induced by cigarette smoking: Novel insights from a [(11)C]-(+)-PHNO PET study in humans. Neuropsychopharmacology 39, 415\u2013424. https:\/\/doi.org\/10.1038\/npp.2013.209 (2014).","journal-title":"Neuropsychopharmacology"},{"key":"90915_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/npp.2013.286","author":"JD Gallezot","year":"2013","unstructured":"Gallezot, J. D. et al. Imaging nicotine- and amphetamine-induced dopamine release in rhesus monkeys with [C]PHNO vs [C]raclopride PET. Neuropsychopharmacology https:\/\/doi.org\/10.1038\/npp.2013.286 (2013).","journal-title":"Neuropsychopharmacology"},{"key":"90915_CR25","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1007\/s00702-018-1957-2","volume":"126","author":"M Solinas","year":"2019","unstructured":"Solinas, M., Belujon, P., Fernagut, P. O., Jaber, M. & Thiriet, N. Dopamine and addiction: What have we learned from 40 years of research. J. Neural Transm. 126, 481\u2013516. https:\/\/doi.org\/10.1007\/s00702-018-1957-2 (2019).","journal-title":"J. Neural Transm."},{"key":"90915_CR26","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1111\/ejn.13964","volume":"49","author":"J Peak","year":"2019","unstructured":"Peak, J., Hart, G. & Balleine, B. W. From learning to action: The integration of dorsal striatal input and output pathways in instrumental conditioning. Eur. J. Neurosci. 49, 658\u2013671. https:\/\/doi.org\/10.1111\/ejn.13964 (2019).","journal-title":"Eur. J. Neurosci."},{"key":"90915_CR27","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1038\/nn1579","volume":"8","author":"BJ Everitt","year":"2005","unstructured":"Everitt, B. J. & Robbins, T. W. Neural systems of reinforcement for drug addiction: From actions to habits to compulsion. Nat. Neurosci. 8, 1481\u20131489 (2005).","journal-title":"Nat. Neurosci."},{"key":"90915_CR28","doi-asserted-by":"publisher","first-page":"6247","DOI":"10.1523\/JNEUROSCI.22-14-06247.2002","volume":"22","author":"R Ito","year":"2002","unstructured":"Ito, R., Dalley, J. W., Robbins, T. W. & Everitt, B. J. Dopamine release in the dorsal striatum during cocaine-seeking behavior under the control of a drug-associated cue. J. Neurosci. 22, 6247\u20136253 (2002).","journal-title":"J. Neurosci."},{"key":"90915_CR29","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1080\/02724990444000023","volume":"58","author":"JA Parkinson","year":"2005","unstructured":"Parkinson, J. A., Roberts, A. C., Everitt, B. J. & Di Ciano, P. Acquisition of instrumental conditioned reinforcement is resistant to the devaluation of the unconditioned stimulus. Q J Exp Psychol B 58, 19\u201330 (2005).","journal-title":"Q J Exp Psychol B"},{"key":"90915_CR30","doi-asserted-by":"publisher","first-page":"8665","DOI":"10.1523\/JNEUROSCI.0925-05.2005","volume":"25","author":"LJ Vanderschuren","year":"2005","unstructured":"Vanderschuren, L. J., Di Ciano, P. & Everitt, B. J. Involvement of the dorsal striatum in cue-controlled cocaine seeking. J. Neurosci. 25, 8665\u20138670 (2005).","journal-title":"J. Neurosci."},{"key":"90915_CR31","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.neuroimage.2010.06.044","volume":"54","author":"AC Tziortzi","year":"2011","unstructured":"Tziortzi, A. C. et al. Imaging dopamine receptors in humans with [11C]-(+)-PHNO: Dissection of D3 signal and anatomy. Neuroimage 54, 264\u2013277. https:\/\/doi.org\/10.1016\/j.neuroimage.2010.06.044 (2011).","journal-title":"Neuroimage"},{"key":"90915_CR32","doi-asserted-by":"publisher","first-page":"960","DOI":"10.2967\/jnumed.113.132928","volume":"55","author":"JD Gallezot","year":"2014","unstructured":"Gallezot, J. D. et al. Parametric imaging and test-retest variability of (1)(1)C-(+)-PHNO binding to D(2)\/D(3) dopamine receptors in humans on the high-resolution research tomograph PET scanner. J. Nucl. Med. 55, 960\u2013966. https:\/\/doi.org\/10.2967\/jnumed.113.132928 (2014).","journal-title":"J. Nucl. Med."},{"key":"90915_CR33","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1080\/1462220031000158681","volume":"5","author":"SJ Heishman","year":"2003","unstructured":"Heishman, S. J., Singleton, E. G. & Moolchan, E. T. Tobacco Craving Questionnaire: Reliability and validity of a new multifactorial instrument. Nicotine Tob. Res. 5, 645\u2013654 (2003).","journal-title":"Nicotine Tob. Res."},{"key":"90915_CR34","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1080\/14622200020032051","volume":"3","author":"LS Cox","year":"2001","unstructured":"Cox, L. S., Tiffany, S. T. & Christen, A. G. Evaluation of the brief questionnaire of smoking urges (QSU-brief) in laboratory and clinical settings. Nicotine Tob. Res. 3, 7\u201316. https:\/\/doi.org\/10.1080\/14622200020032051 (2001).","journal-title":"Nicotine Tob. Res."},{"key":"90915_CR35","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1037\/0022-3514.54.6.1063","volume":"54","author":"D Watson","year":"1988","unstructured":"Watson, D., Clark, L. A. & Tellegen, A. Development and validation of brief measures of positive and negative affect: The PANAS scales. J. Pers. Soc. Psychol. 54, 1063\u20131070 (1988).","journal-title":"J. Pers. Soc. Psychol."},{"key":"90915_CR36","doi-asserted-by":"publisher","first-page":"4153","DOI":"10.1021\/jm050155n","volume":"48","author":"AA Wilson","year":"2005","unstructured":"Wilson, A. A. et al. Radiosynthesis and evaluation of [11C]-(+)-4-propyl-3,4,4a,5,6,10b-hexahydro-2H-naphtho[1,2-b][1,4]oxazin-9-ol as a potential radiotracer for in vivo imaging of the dopamine D2 high-affinity state with positron emission tomography. J. Med. Chem. 48, 4153\u20134160. https:\/\/doi.org\/10.1021\/jm050155n (2005).","journal-title":"J. Med. Chem."},{"key":"90915_CR37","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.pscychresns.2006.01.011","volume":"147","author":"P Rusjan","year":"2006","unstructured":"Rusjan, P. et al. An automated method for the extraction of regional data from PET images. Psychiatry Res. 147, 79\u201389. https:\/\/doi.org\/10.1016\/j.pscychresns.2006.01.011 (2006).","journal-title":"Psychiatry Res."},{"key":"90915_CR38","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1097\/01.WCB.0000048520.34839.1A","volume":"23","author":"D Martinez","year":"2003","unstructured":"Martinez, D. et al. Imaging human mesolimbic dopamine transmission with positron emission tomography. Part II: Amphetamine-induced dopamine release in the functional subdivisions of the striatum. J. Cereb. Blood Flow Metab. 23, 285\u2013300 (2003).","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"90915_CR39","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1523\/JNEUROSCI.4371-11.2012","volume":"32","author":"I Boileau","year":"2012","unstructured":"Boileau, I. et al. Higher binding of the dopamine D3 receptor-preferring ligand [11C]-(+)-propyl-hexahydro-naphtho-oxazin in methamphetamine polydrug users: A positron emission tomography study. J. Neurosci. 32, 1353\u20131359. https:\/\/doi.org\/10.1523\/JNEUROSCI.4371-11.2012 (2012).","journal-title":"J. Neurosci."},{"key":"90915_CR40","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1006\/nimg.1996.0066","volume":"4","author":"AA Lammertsma","year":"1996","unstructured":"Lammertsma, A. A. & Hume, S. P. Simplified reference tissue model for PET receptor studies. Neuroimage 4, 153\u2013158. https:\/\/doi.org\/10.1006\/nimg.1996.0066 (1996).","journal-title":"Neuroimage"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-90915-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-90915-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-90915-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T09:18:26Z","timestamp":1670059106000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-90915-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,3]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["90915"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-90915-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,3]]},"assertion":[{"value":"18 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Dr Le Foll has obtained funding from Pfizer (GRAND Awards, including salary support) for investigator-initiated projects. Dr Le Foll has some in-kind donation of cannabis product from Aurora and medication donation from Pfizer and Bioprojet and was provided a coil for TMS study from Brainsway. Dr Le Foll has obtained industry funding from Canopy (through research grants handled by CAMH or University of Toronto), Bioprojet, ACS and Alkermes. Dr Le Foll has received in kind donations of nabiximols from GW Pharma for past studies funded by CIHR and NIH. He has been consultant for Shionogi. He is supported by CAMH and a clinician-scientist award from the department of Family and Community Medicine of the University of Toronto and an Addiction Psychiatry Chair from the department of Psychiatry of the University of Toronto. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"11667"}}